Beware of Metabolites

Jul 1, 2016 by in ANESTHESIA Comments Off on Beware of Metabolites

Beware of Metabolites Bradford D. Winters MD, PHD Many drugs are metabolized to active metabolites. This is usually carried out by the liver in the form of reductions, oxidations, and…

read more

Strongly Consider Starting an Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker after Myocardial Infarction

Jul 1, 2016 by in ANESTHESIA Comments Off on Strongly Consider Starting an Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker after Myocardial Infarction

Strongly Consider Starting an Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker after Myocardial Infarction Ying Wei Lum MD The renin-angiotensin-aldosterone system (RAAS) regulates aldosterone release in the body via the…

read more

Strongly Consider Using Glycoprotein IIb/IIIa Inhibitors as an Added Treatment to Stenting in Acute Myocardial Infarction

Jul 1, 2016 by in ANESTHESIA Comments Off on Strongly Consider Using Glycoprotein IIb/IIIa Inhibitors as an Added Treatment to Stenting in Acute Myocardial Infarction

Strongly Consider Using Glycoprotein IIb/IIIa Inhibitors as an Added Treatment to Stenting in Acute Myocardial Infarction Nirav G. Shah MD Percutaneous coronary intervention (PCI) with stenting has revolutionized the care…

read more

Strongly Consider Low-Molecular-Weight Heparin in the Treatment of Unstable Angina and Non-ST-Elevation Myocardial Infarction

Jul 1, 2016 by in ANESTHESIA Comments Off on Strongly Consider Low-Molecular-Weight Heparin in the Treatment of Unstable Angina and Non-ST-Elevation Myocardial Infarction

Strongly Consider Low-Molecular-Weight Heparin in the Treatment of Unstable Angina and Non-ST-Elevation Myocardial Infarction Julius Cuong Pham MD Case Mrs. ACS is a 74-year-old female who is admitted to the…

read more
Get Clinical Tree app for offline access